280.10
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Amgen Inc Borsa (AMGN) Ultime notizie
Will Amgen Inc. see short term momentumJuly 2025 Final Week & Verified Momentum Stock Watchlist - Newser
Amgen’s bemarituzumab loses momentum as survival edge fades - The Pharma Letter
FORA Capital LLC Lowers Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Acquired by Evergreen Capital Management LLC - MarketBeat
Canada Pension Plan Investment Board Has $160.91 Million Stock Holdings in Amgen Inc. $AMGN - MarketBeat
EP Wealth Advisors LLC Purchases 8,317 Shares of Amgen Inc. $AMGN - MarketBeat
Panagora Asset Management Inc. Has $32.69 Million Stake in Amgen Inc. $AMGN - MarketBeat
Baird Financial Group Inc. Sells 26,571 Shares of Amgen Inc. $AMGN - MarketBeat
Jump Financial LLC Has $471,000 Position in Amgen Inc. $AMGN - MarketBeat
Flputnam Investment Management Co. Trims Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Royal Bank of Canada Has $1.52 Billion Position in Amgen Inc. $AMGN - MarketBeat
Vident Advisory LLC Cuts Holdings in Amgen Inc. $AMGN - MarketBeat
Stock Analysis | Amgen OutlookNeutral Technicals, Strong Fundamentals, and Mixed Analyst Ratings - AInvest
Has Amgen Inc. found a price floorNew Guidance & Accurate Buy Signal Notifications - Newser
Trend analysis for Amgen Inc. this weekForecast Cut & High Accuracy Trade Alerts - Newser
‘Attenuated’ Survival Benefit In Bemarituzumab Trial Delays Filing Plans - insights.citeline.com
Amgen plans $600M R&D facility at Thousand Oaks HQ - The Real Deal
AMGEN TO PRESENT AT THE MORGAN STANLEY 23RD ANNUAL GLOBAL HEALTHCARE CONFERENCE - MarketScreener
Global Biotech Leader Amgen to Share Business Updates at Morgan Stanley Healthcare Conference 2025 - Stock Titan
Biotech company Amgen set to build $600-million research center in Thousand Oaks - Los Angeles Times
Amgen Faces Setback As Final Data Weakens Case For Gastric Cancer Drug - Benzinga
Gilead, Amgen kick off facility investments in US - pharmaphorum
Should you hold or exit Amgen Inc. nowMarket Risk Analysis & Stock Portfolio Risk Management - Newser
Amgen Inc. stock trend forecastJuly 2025 Fed Impact & Real-Time Chart Pattern Alerts - Newser
Amgen Stock (AMGN) Slips on $600M Research Hub News - TipRanks
Amgen's 32.26% Volume Spike to 124th Rank as Shares Drop 1.07% Pre-Key Biotech Events - AInvest
Amgen Inc. $AMGN Shares Sold by Smead Capital Management Inc. - MarketBeat
The Manufacturers Life Insurance Company Purchases 600,096 Shares of Amgen Inc. $AMGN - MarketBeat
Zacks Research Predicts Amgen's Q3 Earnings (NASDAQ:AMGN) - MarketBeat
Decoding the Genetics of Obesity - Amgen
Amgen, Zai Lab say stomach cancer drug's survival benefit dropped in Phase 3 - Endpoints News
Amgen Inc. (AMGN)’s Experimental Obesity Drug MariTide Shows Up to 20% Weight Loss Potential - MSN
Amgen (AMGN) Unveils US$600 Million Innovation Hub Expanding R&D Efforts in California - simplywall.st
Amgen’s Strategic Focus and Portfolio Strength Justify Buy Rating Despite Bemarituzumab Challenges - TipRanks
Amgen at Wells Fargo Conference: Strategic Growth and Innovation - Investing.com
Amgen dips after trial update for Zai Lab partnered gastric cancer therapy - Seeking Alpha
Amgen Inc. $AMGN Shares Sold by First Manhattan CO. LLC. - MarketBeat
Amgen to Invest $600 Million in New Science and Innovation Center at US Headquarters - geneonline.com
GW Henssler & Associates Ltd. Decreases Stock Holdings in Amgen Inc. $AMGN - MarketBeat
First Financial Bankshares Inc Cuts Position in Amgen Inc. $AMGN - MarketBeat
Ameriflex Group Inc. Has $2.44 Million Stake in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Sold by Lansforsakringar Fondforvaltning AB publ - MarketBeat
Amgen Inc. $AMGN Shares Purchased by Ieq Capital LLC - MarketBeat
Amgen Inc. $AMGN Stock Holdings Increased by Landscape Capital Management L.L.C. - MarketBeat
Trexquant Investment LP Sells 36,293 Shares of Amgen Inc. $AMGN - MarketBeat
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):